Cargando…
Using real world data to assess cardiovascular outcomes of two antidiabetic treatment classes
AIM: To evaluate the effect on cardiovascular outcomes of sodium-glucose co-transporter-2 (SGLT2) inhibitors in a real world setting by analyzing electronic medical records. METHODS: We used TriNetX, a global federated research network providing statistics on electronic health records (EHR). The ana...
Autor principal: | Stapff, Manfred Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304296/ https://www.ncbi.nlm.nih.gov/pubmed/30588287 http://dx.doi.org/10.4239/wjd.v9.i12.252 |
Ejemplares similares
-
Impact of diabetes mellitus on risk of cardiovascular disease and all-cause mortality: Evidence on health outcomes and antidiabetic treatment in United States adults
por: Liu, Longjian, et al.
Publicado: (2016) -
Driving Pressure, Elastance, and Outcomes in a Real-World Setting: A Bi-Center Analysis of Electronic Health Record Data
por: Goodwin, Andrew J., et al.
Publicado: (2023) -
Real-world data on the infliximab biosimilar CT-P13 (Remsima(®)) in inflammatory bowel disease
por: Huguet, Jose María, et al.
Publicado: (2021) -
Interferon-free treatments in patients with hepatitis C genotype 1-4 infections in a real-world setting
por: Ramos, Huascar, et al.
Publicado: (2017) -
Real-world disease activity and sociodemographic, clinical and treatment characteristics of moderate-to-severe inflammatory bowel disease in Brazil
por: Zaltman, Cyrla, et al.
Publicado: (2021)